1. Generic & Brand Names
Generic: Pseudoephedrine HCl/Sulfate
Brands: Sudafed® (Global), Nexafed®, SudoGest®
Combinations: Claritin-D® (loratadine), Allegra-D® (fexofenadine), Zyrtec-D® (cetirizine)
2. Mechanism of Action
α-Adrenergic agonist → vasoconstricts nasal blood vessels
Reduces swelling/inflammation of nasal mucosa
Onset: 30 min (oral); Duration: 4-6h (IR), 12h (ER)
3. FDA-Approved Uses
Nasal/Sinus Congestion:
Colds, allergies (allergic rhinitis), sinusitis
Eustachian Tube Dysfunction:
Air travel, barotrauma prevention
4. Dosing & Administration
| Formulation | Adults | Children (6-12 yrs) |
|---|---|---|
| IR Tablets | 60 mg q4-6h | 30 mg q4-6h |
| ER Tablets | 120 mg q12h | Not recommended |
| Liquid (15mg/5mL) | - | 5 mL q4-6h |
| Max Daily: 240 mg (adults), 120 mg (children) | ||
| Critical Notes: |
Last dose before 5 PM → prevents insomnia
Take with food to reduce GI upset
Avoid in children <6 years (seizure risk)
5. Side Effects
| Common (≥10%) | Serious (Discontinue) |
|---|---|
| Insomnia | Hypertensive crisis (≥180/110 mmHg) |
| Nervousness | Tachycardia (>120 bpm) |
| Tachycardia | Arrhythmias |
| Dry mouth | Acute angle-closure glaucoma |
| Headache | Seizures (pediatric) |
6. Black Box Warnings & Contraindications
🚫 Absolute Contraindications:
Uncontrolled hypertension
Coronary artery disease
MAOI use (within 14 days)
Severe prostate enlargement
High-Risk Groups:
Elderly (>65 yrs): ↑ CNS stimulation
Hyperthyroidism: ↑ cardiac strain
Diabetes: May ↑ blood glucose
7. Drug Interactions
| Medication | Risk |
|---|---|
| MAO Inhibitors | Hypertensive crisis (fatal) |
| Beta-Blockers | Unopposed α-effects → severe HTN |
| Stimulants | Additive tachycardia (ADHD meds, caffeine) |
| Antihypertensives | Reduced efficacy of BP medications |
8. Regulatory Status (USA)
Combat Methamphetamine Act (2005):
Sold "behind-the-counter" in pharmacies
Photo ID required + electronic tracking (NPLEx)
Purchase limits: 3.6g/day, 9g/month
No mail-order sales
9. Clinical Pearls
✅ Proven Efficacy:
Superior to phenylephrine (90-100% vs. <1% bioavailability)
Reduces nasal airflow resistance by 35% (Rhinology)
❌ Avoid When:Productive cough (dries secretions)
Late pregnancy (Category C)
⚠️ Safety Monitoring:Check BP before/during use in hypertensives
Screen for glaucoma symptoms (eye pain, blurred vision)
10. Overdose Management
Symptoms:
Severe hypertension, hallucinations, cardiac arrhythmias
Treatment:
IV phentolamine (α-blocker)
Benzodiazepines for agitation/seizures
Avoid β-blockers (unopposed α-stimulation)
Why It's Still the Gold Standard
Despite restrictions, pseudoephedrine remains the most effective oral decongestant:
Works in 30 minutes vs. hours for alternatives
94% patients report significant congestion relief (Annals of Internal Medicine)
ER formulations provide 12-hour coverage
Alternatives:
For mild cases: Intranasal saline sprays
Allergy-related: Intranasal corticosteroids (e.g., fluticasone)
High-risk patients: Oxymetazoline nasal spray (max 3 days)
📌 Key Reminder: Always verify ID and track sales per state/federal law to prevent methamphetamine production.
Comments
Post a Comment